Life sciences and healthcare enterprises are being significantly disrupted by COVID-19. It’s transforming healthcare, accelerating pharma’s shift to digital, and turning long-term planning upside down.
Life Sciences is a priority at Capgemini, and it’s our fastest-growing sector. We’ve been active in this field for over 30 years and have over 13,000 specialists. Our client list spanning over 40 countries, includes over 100 global leading biopharma companies, where we are delivering end-to-end digital transformation and technology services from strategy to implementation at scale.
Our approach is ‘people-first’, putting patients, providers, team members, and partners, at the centre of everything we do: from inventing a novel experience for patients to co-creating new operating models and globally implementing a new technology platform.